Order Article Reprints

Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, et al. Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma. Cancers. 2024; 16(7):1328. https://doi.org/10.3390/cancers16071328

Shirane, Yuki, Yasutoshi Fujii, Atsushi Ono, Hikaru Nakahara, Clair Nelson Hayes, Ryoichi Miura, Serami Murakami, Naoya Sakamoto, Shinsuke Uchikawa, Hatsue Fujino, and et al. 2024. "Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma" Cancers 16, no. 7: 1328. https://doi.org/10.3390/cancers16071328

Shirane, Y., Fujii, Y., Ono, A., Nakahara, H., Hayes, C. N., Miura, R., Murakami, S., Sakamoto, N., Uchikawa, S., Fujino, H., Nakahara, T., Murakami, E., Yamauchi, M., Miki, D., Kawaoka, T., Arihiro, K., Tsuge, M., & Oka, S. (2024). Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma. Cancers, 16(7), 1328. https://doi.org/10.3390/cancers16071328